Giltuss Childrens Multisymptom Cold And Flu Solution
NDC Package 58552-137-04
Package Information
Giltuss Childrens Multisymptom Cold And Flu (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride) solution is uses temporarily relieves:minor aches and painsheadacheminor sore throat painrunny noseitchy nose or throatsneezingitchy watery eyes due to hay fevernasal and sinus congestioncough due to minor throat and bronchial irritation as may occur with a coldtemporarily reduces fever. This formulation utilizes a solution delivery system. Marketed by Giltuss Pharmaceutical Corp, this product is identified by NDC 58552-137 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2121065 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 6.5 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution
- RxCUI: 2121065 - acetaminophen 65 MG/ML / chlorpheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 1.3 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution
- RxCUI: 2121065 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 6.5 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution
- RxCUI: 2121065 - APAP 65 MG/ML / Chlorpheniramine Maleate 0.4 MG/ML / Dextromethorphan Hydrobromide 1.3 MG/ML / Phenylephrine Hydrochloride 1 MG/ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 58552 - Giltuss Pharmaceutical Corp
- 58552-137 - Giltuss Childrens Multisymptom Cold And Flu
- 58552-137-04 - 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
- 58552-137 - Giltuss Childrens Multisymptom Cold And Flu
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58552-137-04 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Giltuss Childrens Multisymptom Cold And Flu, a human over the counter drug labeled by Giltuss Pharmaceutical Corp. This solution is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Giltuss Pharmaceutical Corp on October 02, 2018. The current certification is valid through December 31, 2026.
How is this Giltuss Pharmaceutical Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58552013704. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.